Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation

Figure 1 Cumulative incidence of new-onset diabetes mellitus over a 10-year period after liver transplantation. NODM: New-onset diabetes mellitus.

Figure 2 Survival rates of liver recipients in non-new-onset diabetes mellitus and new-onset diabetes mellitus groups. A: Overall survival rates (P < 0.05); B: Allograft survival rates (P < 0.05). NODM: New-onset diabetes mellitus; LT: Liver transplantation.

Figure 3 Receiver operating characteristic curve for mean cTAC after 6 mo to predict new-onset diabetes mellitus after transplantation.

Figure 4 Survival rates of recipients in low and high mean tacrolimus trough concentration groups (P < 0. 05). A: Allograft survival rates; B: Overall survival rate (P = 0.129). Low mean cTAC group: mean cTAC < 5.89 ng/mL; High cTAC group: mean cTAC ≥ 5.89 ng/mL. cTAC: Tacrolimus trough concentration; LT: Liver transplantation.